A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS
Conditions
- Ankylosing Spondylitis
- Therapeutic Agent Toxicity
Interventions
- PROCEDURE: intermittent treatment
- PROCEDURE: continuous treatment
Sponsor
Shanghai Zhongshan Hospital
Collaborators